** Medical device maker CytoSorbents Corp shares CTSO.O up
9.8% at $2 before the bell
** Co says Israeli Ministry of Health has approved national
reimbursement for co's CytoSorb blood purification therapy for
cardiac surgeries urn:newsml:reuters.com:*:nPn1zPwLva
** The national reimbursement is expected to be effective in
2023
** More than 4,000 heart surgeries are performed in Israel
each year - CTSO
** Up to Tuesday's close, stock lost ~56% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))